References
- Mu P, Zhang Z, Benelli M, Karthaus W, Hoover E, Chen C, Wongvipat J, Ku S, Gao D, Cao Z, et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science 2017; 355(6320):84-88; PMID:28059768; https://doi.org/10.1126/science.aah4307
- Wang HT, Yao YH, Li BG, Tang Y, Chang JW, Zhang J. Neuroendocrine Prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: Factors associated with time to development of NEPC and survival from NEPC diagnosis-a systematic review and pooled analysis. J Clin Oncol 2014; 32(30):3383-90; PMID:25225419; https://doi.org/10.1200/JCO.2013.54.3553
- Weina K, Utikal J. SOX2 and cancer: Current research and its implications in the clinic. Clin Transl Med 2014; 3:19; PMID:25114775; https://doi.org/10.1186/2001-1326-3-19
- Choi YJ, Lin CP, Ho JJ, He X, Okada N, Bu P, Zhong Y, Kim SY, Bennett MJ, Chen C, et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 2011; 13(11):1353-60; PMID:22020437; https://doi.org/10.1038/ncb2366
- Stolzenburg S, Rots MG, Beltran AS, Rivenbark AG, Yuan X, Qian H, Strahl BD, Blancafort P. Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer. Nucleic Acids Res 2012; 40(14):6725-40; PMID:22561374; https://doi.org/10.1093/nar/gks360
- Li Y, Chen K, Li L, Li R, Zhang J, Ren W. Overexpression of SOX2 is involved in paclitaxel resistance of ovarian cancer via the PI3K/Akt pathway. Tumour Biol 2015; 36(12):9823-8; PMID:26159849; https://doi.org/10.1007/s13277-015-3561-5
- Gaudreau PO, Stagg J, Soulières D, Saad F. The present and future of biomarkers in prostate cancer: Proteomics, genomics, and immunology advancements. Biomark Cancer 2016; 8(Suppl 2):15-33; PMID:27168728; https://doi.org/10.4137/BIC.S31802
- Favaro R, Appolloni I, Pellegatta S, Sanga AB, Pagella P, Gambini E, Pisati F, Ottolenghi S, Foti M, Finocchiaro G, et al. Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma. Cancer Res 2014; 74(6):1833-44; PMID:24599129; https://doi.org/10.1158/0008-5472.CAN-13-1942
- Ku SY, Rosario S, Wang Y, Mu P, Seshadri M, Goodrich ZW, Goodrich MM, Labbé DP, Gomez EC, Wang J, et al. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Science 2017; 355(6320):78-83; PMID:28059767; https://doi.org/10.1126/science.aah4199